The U.S. Food and Drug Administration has given a physician approval to test a drug for its effectiveness in fighting MRSA infections, according to a WPTV news report.
Robert Berman, MD, a general surgeon from Jupiter, Fla., created a prescription gel called Vancogel, which aims to stop the spread of MRSA infections in patients. The gel, which is applied to cuts up to 50 cm deep, differs from traditional MRSA oral treatments and IV medications. The clinical trials will take place from Aug. 1 through December.
Read the news report about Vancogel.
Related Articles on MRSA:
Milwaukee Hospital Cut Funding From Infection Control, Physician Claims
Researchers Discover New Strain of MRSA That May Go Undetected Under Testing
14 Babies at Alaska's Providence Hospital Infected by MRSA Since March
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Robert Berman, MD, a general surgeon from Jupiter, Fla., created a prescription gel called Vancogel, which aims to stop the spread of MRSA infections in patients. The gel, which is applied to cuts up to 50 cm deep, differs from traditional MRSA oral treatments and IV medications. The clinical trials will take place from Aug. 1 through December.
Read the news report about Vancogel.
Related Articles on MRSA:
Milwaukee Hospital Cut Funding From Infection Control, Physician Claims
Researchers Discover New Strain of MRSA That May Go Undetected Under Testing
14 Babies at Alaska's Providence Hospital Infected by MRSA Since March
